Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Alexander GG Turpie,1 André C Schmidt,2 Reinhold Kreutz,3 Michael R Lassen,4 Waheed Jama,1,2 Lorenzo Mantovani,5 Sylvia Haas61Department of Medicine, Hamilton Health Sciences, General Division, Ontario, Canada; 2Bayer Healthcare Pharmaceuticals, Global Development, Berlin, Germany; 3I...

Full description

Bibliographic Details
Main Authors: Turpie AG, Schmidt AC, Kreutz R, Lassen MR, Jamal W, Mantovani L, Haas S
Format: Article
Language:English
Published: Dove Medical Press 2012-06-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/rationale-and-design-of-xamos-noninterventional-study-of-rivaroxaban-f-a10018